Korean J Physiol Pharmacol.
1997 Jun;1(3):297-302.
Inhibition by higenamine of lipopolysaccharide-induced iNOS and mRNA
expression and NO production in rat aorta
- Affiliations
-
- 1Department of Pharmacology, College of Medicine, GyeongSang National University, Chinju 660-280, Korea.
- 2Cardiovascular Research Institute, College of Medicine, GyeongSang National University, Chinju 660-280, Korea.
Abstract
-
Higenamine was widely used as traditional remedy for the treatment of
rheumatoid arthritis. Nitric oxide (NO) may be a critical mediator in
this inflammatory disease. Synovial tissue from humans with
inflammatory arthritis expresses NOS2 (iNOS) mRNA and protein, and
generates NO in vitro. We therefore, investigated the effect of
higenamine on the induction of nitric oxide synthase (NOS) promoted by
lipopolysaccharide (LPS). Prophylactic application of higenamine
selectively prevented LPS-primed initiation of L-arginine-induced
relaxation and restored phenylephrine(PE)-induced contraction in rat
aorta. LPS-stimulated nitrite production in the incubation medium was
reduced by higenamine. Furthermore, RT-PCR and Northern analysis
indicated that higenamine reduced iNOS expression primed by LPS in rat
aorta. These results suggest that higenamine prevents LPS-promoted
induction of NOS in vascular smooth muscle.